Facts, values, and attention-deficit hyperactivity disorder (ADHD): An update on the controversies

Child and Adolescent Psychiatry and Mental Health

Volumn 3, Issue , 2009, Pages

  Parens, Erik ^a   Johnston, Josephine ^a  

^a HASTINGS CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

ACADEMIC ACHIEVEMENT; AMBIGUITY; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CHILD PARENT RELATION; CHILD PSYCHIATRY; COMMUNITY LIVING; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG USE; EMOTIONAL DISORDER; ENVIRONMENTAL FACTOR; EXPECTATION; FAMILY DECISION MAKING; HEALTH CARE PERSONNEL; HOME ENVIRONMENT; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SYMPTOM; WORKSHOP;

EID: 60849135717     PISSN: None     EISSN: 17532000     Source Type: Journal    
DOI: 10.1186/1753-2000-3-1     Document Type: Article

References (86)

1. Pastor PN Reuben CA Diagnosed Attention Deficit Hyperactivity Disorder and Learning Disability: United States, 2004-2005 Vital Health Stat National Center for Health Statistics 2008:10.
2. Safer DJ Zito JM Fine EM Increased methylphenidate usage for attention deficit disorder in the 1990s Pediatrics 1996, 98:1084-1088. 8951257
3. Zito JM Safer DJ dosReis S Gardner JF Boles M Lynch F Trends in the prescribing of psychotropic medications to preschoolers JAMA 2000, 283:1025-1030. 10.1001/jama.283.8.1025 10697062
4. Habel LA Schaefer CA Levine P Bhat AK Elliott G Treatment with stimulants among youths in a large California health plan J Child Adolesc Psychopharmacol 2005. 15:62-67. 10.1089/cap.2005.15.62 15741787
5. Schwabe U Paffrath D Arzneiverordnungs-Report 2006 Berlin: Springer 2006
6. Psychotropic Drugs: Statistics for 2005: Assessment of annual medical and scientific requirements for substances in schedules II, III and IV New York: United Nations Office on Drugs and Crime 2007
7. Amaral OB Psychiatric disorders as social constructs: ADHD as a case in point Am J Psychiatry 2007, 164:1612-1613. 10.1176/ appi.ajp.2007.07060942 17898357
8. Posters Most Relevant to Child and Adolescent Psychopharmacology: The 46th Annual National Institute of Mental Health (NIMH) New Clinical Drug Evaluation Unit (NCDEU) Meeting, Boca Raton, Florida, USA, June 12-15, 2006 J Child Adolesc Psychopharmacol 2006, 16:649-664. 10.1089/ cap.2006.16.649 17201609
9. Pelham WEJ Center for Children and Families, State University of New York at Buffalo Against the Grain: A Psychosocial-first Approach to Treating ADHD - the Buffalo Treatment Algorithm Attention Deficit Hyperactivity Disorder: A 21st Century Perspective Edited by Pfiffner L&MK 2007
10. Schirm E Tobi H Zito JM de Jong-van den Berg LT Psychotropic medication in children: A study from the Netherlands Pediatrics 2001, 108:E25. 10.1542/peds.108.2.e25 11483835
11. Rushton JL Whitmire JT Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998 Arch Pediatr Adolesc Med 2001, 155:560-565. 11343498
12. Zuvekas SH Vitiello B Norquist GS Recent trends in stimulant medication use among U.S. children Am J Psychiatry 2006, 163:579-585. 10.1176/ appi.ajp.163.4.579 16585430
13. Parens E Johnston J Understanding the agreements and controversies surrounding childhood psychopharmacology Child Adolesc Psychiatry Ment Health 2008, 2:5. 2275214 18261228 10.1186/1753-2000-2-5
14. Sax L Kautz KJ Who first suggests the diagnosis of attention-deficit/ hyperactivity disorder? Ann Fam Med 2003, 1:171-174. 1466583 15043379 10.1370/afm.3
15. Task Force on DSM-IV and other committees and work groups of the American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders Washington, DC: American Psychiatric Association 4 2004
16. McClellan J Werry J Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. American Academy of Child and Adolescent Psychiatry J Am Acad Child Adolesc Psychiatry 1997, 36:157S-176S. 10.1097/00004583-199707000-00018 9432516
17. Todd RD Huang H Todorov AA Neuman RJ Reiersen AM Henderson CA Reich WC Predictors of stability of attention-deficit/hyperactivity disorder subtypes from childhood to young adulthood J Am Acad Child Adolesc Psychiatry 2008, 47:76-85. 18174828
18. Tannock R Attention deficit hyperactivity disorder: Advances in cognitive, neurobiological, and genetic research J Child Psychol Psychiatry 1998, 39:65-99. 10.1017/S0021963097001777 9534087
19. Bush G Neuroimaging of attention deficit hyperactivity disorder: Can new imaging findings be integrated in clinical practice? Child Adolesc Psychiatr Clin N Am 2008, 17:385-404. 10.1016/j.chc.2007.11.002 18295152
20. Shaw P Gornick M Lerch J Addington A Seal J Greenstein D Sharp W Evans A Giedd JN Castellanos FX Rapoport JL Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/ hyperactivity disorder Arch Gen Psychiatry 2007, 64:921-931. 10.1001/ archpsyc.64.8.921 17679637
21. Shaw P Eckstrand K Sharp W Blumenthal J Lerch JP Greenstein D Clasen L Evans A Giedd J Rapoport JL Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation Proc Natl Acad Sci USA 2007, 104:19649-19654. 2148343 18024590 10.1073/pnas.0707741104
22. Kendler KS "A gene for...": The nature of gene action in psychiatric disorders Am J Psychiatry 2005, 162:1243-1252. 10.1176/ appi.ajp.162.7.1243 15994704
23. Mick E Faraone SV Genetics of attention deficit hyperactivity disorder Child Adolesc Psychiatr Clin N Am 2008, 17:261-viii. 10.1016/ j.chc.2007.11.011 18295146
24. Sonuga-Barke EJ Causal models of attention-deficit/hyperactivity disorder: From common simple deficits to multiple developmental pathways Biol Psychiatry 2005, 57:1231-1238. 10.1016/j.biopsych.2004.09.008 15949993
25. Wolraich ML Hannah JN Baumgaertel A Feurer ID Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample J Dev Behav Pediatr 1998, 19:162-168. 10.1097/ 00004703-199806000-00003 9648041
26. Hinshaw SP Externalizing behavior problems and academic underachievement in childhood and adolescence: Causal relationships and underlying mechanisms Psychol Bull 1992, 111:127-155. 10.1037/0033-2909.111.1.127 1539086
27. Barkley RA Attention-deficit hyperactivity disorder Child Psychopathology New York: Guildford Press Mash EJ, Barkley RA 2006:63-112.
28. Swanson JM Sergeant JA Taylor E Sonuga-Barke EJ Jensen PS Cantwell DP Attention-deficit hyperactivity disorder and hyperkinetic disorder Lancet 1998, 351:429-433. 10.1016/S0140-6736(97)11450-7 9482319
29. Pelham WE Foster EM Robb JA The economic impact of attention-deficit/ hyperactivity disorder in children and adolescents J Pediatr Psychol 2007, 32:711-727. 10.1093/jpepsy/jsm022 17556402
30. Polanczyk G de Lima MS Horta BL Biederman J Rohde LA The worldwide prevalence of ADHD: A systematic review and metaregression analysis Am J Psychiatry 2007, 164:942-948. 10.1176/appi.ajp.164.6.942 17541055
31. Santosh PJ Taylor E Swanson J Wigal T Chuang S Davies M Greenhill L Newcorn J Arnold LE Jensen P Vitiello B Elliott G Hinshaw S Hechtman L Abikoff H Pelham W Hoza B Molina B Wells K Epstein J Posner M Refining the diagnoses of inattention and overactivity syndromes: A reanalysis of the Multimodal Treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder Clinical Neuroscience Research 2005, 5:307-314. 10.1016/j.cnr.2005.09.010
32. Zito JM Safer DJ craig TJ Pharmacoepidemiology of childhood disorders pharmacoepidemiology and therapeutic risk management Cincinnati: Harvey Whitney Books Hartzema AG, Tilson HH, Chan KA 2008:817-854.
33. Cox ER Motheral BR Henderson RR Mager D Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample Pediatrics 2003, 111:237-243. 10.1542/peds.111.2.237 12563045
34. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder - United States, 2003 MMWR Morb Mortal Wkly Rep 2005, 54:842-847. 16138075
35. Rappley MD Gardiner JC Jetton JR Houang RT The use of methylphenidate in Michigan Arch Pediatr Adolesc Med 1995, 149:675-679. 7767425
36. Ashton CM Petersen NJ Souchek J Menke TJ Yu HJ Pietz K Eigenbrodt ML Barbour G Kizer KW Wray NP Geographic variations in utilization rates in Veterans Affairs hospitals and clinics N Engl J Med 1999, 340:32-39. 10.1056/NEJM199901073400106 9878643
37. Wennberg JE Fisher ES Skinner JS Geography and the debate over Medicare reform Health Aff (Millwood) 2002: Suppl Web Exclusives W96-114. 12703563
38. Wennberg JE Fisher ES Goodman DC Skinner JS Tracking the Care of Patients with Severe Chronic Illness: The Dartmouth Atlas of Health Care 2008 The Dartmouth Institute for Health Policy and Clinical Practice 2008
39. Rushton JL Fant KE Clark SJ Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder Pediatrics 2004, 114:e23-e28. 10.1542/peds.114.1.e23 15231969
40. Chan E Hopkins MR Perrin JM Herrerias C Homer CJ Diagnostic practices for attention deficit hyperactivity disorder: A national survey of primary care physicians Ambul Pediatr 2005, 5:201-208. 10.1367/ A04-054R1.1 16026184
41. McLeod JD Fettes DL Jensen PS Pescosolido BA Martin JK Public knowledge, beliefs, and treatment preferences concerning attention-deficit hyperactivity disorder Psychiatr Serv 2007, 58:626-631. 2365911 17463342 10.1176/appi.ps.58.5.626
42. Angold A Erkanli A Egger HL Costello EJ Stimulant treatment for children: A community perspective J Am Acad Child Adolesc Psychiatry 2000, 39:975-984. 10.1097/00004583-200008000-00009 10939226
43. Diller LH Running on Ritalin: A physician reflects on children, society, and performance in a pill New York, NY: Bantam Books 1998
44. Zito JM Safer DJ DosReis S Gardner JF Magder L Soeken K Boles M Lynch F Riddle MA Psychotropic practice patterns for youth: A 10-year perspective Arch Pediatr Adolesc Med 2003, 157:17-25. 12517190
45. Lyons JS MacIntyre JC Lee ME Carpinello S Zuber MP Fazio ML Psychotropic medications prescribing patterns for children and adolescents in New York's public mental health system Community Ment Health J 2004, 40:101-118. 10.1023/B:COMH.0000022731.65054.3e 15206636
46. Froehlich TE Lanphear BP Epstein JN Barbaresi WJ Katusic SK Kahn RS Prevalence, recognition, and treatment of attention-deficit/ hyperactivity disorder in a national sample of US children Arch Pediatr Adolesc Med 2007, 161;857-864. 10.1001/archpedi.161.9.857 17768285
47. dosReis S Zito JM Safer DJ Soeken KL Mental health services for youths in foster care and disabled youths Am J Public Health 2001, 91:1094-1099. 1446701 11441737 10.2105/AJPH.91.7.1094
48. Conrad P The Medicalization of Society: On the Transformation of Human Conditions Into Treatable Disorders Baltimore: Johns Hopkins University Press 2007
49. Carey WB McDevitt SC Coping With Children's Temperament: A Guide for Professionals New York: Basic Books 1995
50. Carey WB Is ADHD a Valid Disorder? Attention-Deficit/Hyperactivity Disorder. State of the Science. Best Practices Kingston: Civic Research Institute Jensen PS, Cooper JR 2002
51. Parens E Authenticity and ambivalence: Toward understanding the enhancement debate Hastings Cent Rep 2005, 35:34-41. 10.1353/ hcr.2005.0067 16092400
52. Moffitt TE Melchior M Why does the worldwide prevalence of childhood attention deficit hyperactivity disorder matter? Am J Psychiatry 2007, 164:856-858. 1994964 17541041 10.1176/appi.ajp.164.6.856
53. Polanczyk G Rohde LA Drs. Polanczyk and Rohde reply [to Amaral] American Journal of Psychiatry 2007, 164:1612-1613. 10.1176/ appi.ajp.2007.07060942r 17898357
54. DuPaul GJ Rutherford LE Hosterman SJ Attention-Deficit/Hyperactivity Disorder evidence-based interventions for students with learning and behavioral challenges New York: Routledge Morris RJ, Mather N 2008:33-58.
55. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD Arch Gen Psychiatry 1999, 56:1073-1086. 10.1001/archpsyc.56.12.1073 10591283
56. Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder Pediatrics 2001, 108:1033-1044. 10.1542/peds.108.4.1033 11581465
57. Pliszka S Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 2007, 46:894-921. 10.1097/ chi.0b013e318054e724 17581453
58. Carey WB What the multimodal treatment study of children with attention deficit/hyperactivity disorder did and did not say about the use of methylphenidate for attention deficits Pediatrics 2000, 105:863-864. 10.1542/peds.105.4.863 10742336
59. National Institute of Mental Health Collaborative Study Finds Effective Treatments for Attention-Deficit/Hyperactivity Disorder Press Release 1999
60. Jensen PS Arnold LE Swanson JM Vitiello B Abikoff HB Greenhill LL Hechtman L Hinshaw SP Pelham WE Wells KC Conners CK Elliott GR Epstein JN Hoza B March JS Molina BS Newcorn JH Severe JB Wigal T Gibbons RD Hur K 3-year follow-up of the NIMH MTA study J Am Acad Child Adolesc Psychiatry 2007, 46:989-1002. 10.1097/CHI.0b013e3180686d48 17667478
61. Fabiano GA Pelham WE Gnagy EM Burrows-MacLean L Coles EK Chacko A et al. The single and combined effects of multiple intensities of behavior modification and multiple intensities of methylphenidate in a classroom setting School Psychology Review 2007, 36:195-216.
62. Pelham WE Burrows-Maclean L Gnagy EM Fabiano GA Coles EK Tresco KE Chacko A Wymbs BT Wienke AL Walker KS Hoffman MT Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD Exp Clin Psychopharmacol 2005, 13:111-126. 10.1037/ 1064-1297.13.2.111 15943544
63. Jensen PS Hinshaw SP Swanson JM Greenhill LL Conners CK Arnold LE Abikoff HB Elliott G Hechtman L Hoza B March JS Newcorn JH Severe JB Vitiello B Wells K Wigal T Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers J Dev Behav Pediatr 2001, 22:60-73. 11265923
64. Loe IM Feldman HM Academic and educational outcomes of children with ADHD J Pediatr Psychol 2007, 32:643-654. 10.1093/jpepsy/jsl054 17569716
65. Pelham WE Fabiano GA State University of New York at Buffalo Evidence-based psychosocial treatment for attention-deficit/ hyperactivity disorder: An update Journal of Clinical Child and Adolescent Psychology 2007
66. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment Pediatrics 2004, 113:762-769. 10.1542/peds.113.4.762 15060225
67. Swanson J Greenhill L Wigal T Kollins S Stehli A Davies M Chuang S Vitiello B Skrobala A Posner K Abikoff H Oatis M McCracken J McGough J Riddle M Ghuman J Cunningham C Wigal S Stimulant-related reductions of growth rates in the PATS J Am Acad Child Adolesc Psychiatry 2006, 45:1304-1313. 10.1097/01.chi.0000235075.25038.5a 17023868
68. Swanson JM Elliott GR Greenhill LL Wigal T Arnold LE Vitiello B Hechtman L Epstein JN Pelham WE Abikoff HB Newcorn JH Molina BS Hinshaw SP Wells KC Hoza B Jensen PS Gibbons RD Hur K Stehli A Davies M March JS Conners CK Caron M Volkow ND Effects of stimulant medication on growth rates across 3 years in the MTA follow-up J Am Acad Child Adolesc Psychiatry 2007, 46:1015-1027. 10.1097/chi.0b013e3180686d7e 17667480
69. Vitiello B Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function Child Adolesc Psychiatr Clin N Am 2008, 17:459-74. xi 10.1016/j.chc.2007.11.010 18295156
70. Connor DF Meltzer BM Pediatric Psychopharmacology New York: W W Nortonn & Company 2006
71. Mannuzza S Klein RG Truong NL Moulton JL 3rd Roizen ER Howell KH Castellanos FX Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: Prospective follow-up into adulthood Am J Psychiatry 2008, 165:604-609. 10.1176/ appi.ajp.2008.07091465 18381904
72. Pelham WE Jr Fabiano GA Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder J Clin Child Adolesc Psychol 2008, 37:184-214. 10.1080/15374410701818681 18444058
73. DuPaul GJ Stoner G ADHD in schools: Assessment and intervention strategies New York: Guilford Press 2 2003
74. Sadler JZ Values and Psychiatric Diagnosis Oxford, UK: Oxford University Press 2005
75. Parens E Is better always good? Enhancing Human Traits: Ethical and Social Implications Georgetown: Georgetown University Press 1998:1-28.
76. Elliott C Better than well: American medicine meets the American dream New York: W. W. Norton and Company 2003
77. Singh I Clinical implications of ethical concepts: Moral self-understandings in children taking methylphenidate for ADHD Clin Child Psychol Psychiatry 2007, 12:167-182. 10.1177/1359104507075920 17533932
78. Klerman GL Psychotropic hedonism vs. pharmacological Calvinism Hastings Cent Rep 1972, 2:1-3. 4679711
79. Smith DH Stuck in the middle Hastings Cent Rep 2006, 36:32-33. 10.1353/ hcr.2006.0017 16544838
80. Informed consent, parental permission, and assent in pediatric practice. Committee on Bioethics, American Academy of Pediatrics Pediatrics 1995, 95:314-317. 7838658
81. Alderson P Sutcliffe K Curtis K Children's competence to consent to medical treatment Hastings Cent Rep 2006, 36:25-34. 10.1353/ hcr.2006.0000 17278870
82. Bukstein OG Satisfaction with treatment for attention-deficit/ hyperactivity disorder Am J Manag Care 2004, 10:S107-S116. 15352537
83. Floersch J Townsend L Longhofer J Munson M Winbush V Kranke D Faber R Thomas J Jenkins JH Findling R Adolescent Experience of Psychotropic Treatment Transcultural Psychiatry 2008
84. National Initiative for Children's Healthcare Quality Improving Care for Children with ADHD Boston, MA: National Initiative for Children's Healthcare Quality 2003
85. Angell M The truth about drug companies: How they deceive us and what to do about it New York: Random House Publishers 2004
86. Harkness H Raeff C Super C Variability in the social construction of the child: New directions for child and adolescent development San Francisco: Jossey Bass 2000